Anti-PD-1 Antibody Combined With Anlotinib in the Treatment of Endometrial Cancer
Clinical trial NCT04157491 · UNKNOWN
Trial details
- NCT number
- NCT04157491
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-18
- Primary completion
- 2020-12-31
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.